Live Breaking News & Updates on Mihael Polymeropoulos

Stay updated with breaking news from Mihael polymeropoulos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript February 7, 2024 Vanda Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, […] ....

Tim Williams , Mihael Polymeropoulos , Kevin Moran , Quality Essential Oil Brands , Federal Securities , Risk Factors , Financial Condition , General Counsel , New Drug Application , Anda Pharmaceuticals Inc , Mihael Polymeropoulos , Tim Williams , Financial Results , Conference Operator ,

Vanda stock jumps on $100M license deal for MS drug from J&J unit (NASDAQ:VNDA)

Vanda stock jumps on $100M license deal for MS drug from J&J unit (NASDAQ:VNDA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mihael Polymeropoulos , Health Canada , Vanda Pharmaceuticals , Sanofi Genzyme ,

Vanda Pharma stock rises after FDA accepts gastroparesis drug for review (NASDAQ:VNDA)

Vanda Pharma stock rises after FDA accepts gastroparesis drug for review (NASDAQ:VNDA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mihael Polymeropoulos , Vanda Pharma , Eli Lilly , Expanded Access ,

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call. ....

United States , New Jersey , Mihael Polymeropoulos , Mihaelh Polymeropoulos , Tim Williams , Andrew Tsai , Kevin Moran , Circuit Court , Vanda Pharmaceuticals Inc , Vanda Pharmaceuticals , Call Transcript July , Chief Financial , Vanda Pharmaceutical , Chief Executive Officer , Risk Factors , Financial Condition , General Counsel , Orphan Drug Designation , Antisense Oligonucleotide , Federal Circuit , Federal Circuit Court , Lanham Act , Federal Claims ,

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2023 Earnings Call Transcript

Operator: Good afternoon. My name is David and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Q1 2023 Vanda Pharmaceuticals Inc. ....

United States , Kevin Moran , Timothy Williams , Tim Williams , Mihael Polymeropoulos , Vanda Pharmaceuticals , Delaware District Court , Vanda Pharmaceuticals Inc , Circuit Court , Dc District Court , Fourth Circuit Court , Court Circuit , Call Transcript May , Earnings Conference , Vanda Pharmaceutical , Chief Financial Officer , Chief Executive Officer , Risk Factors , Financial Condition , General Counsel , Federal Circuit Court , Federal Circuit , Federal Court Circuit , Federal Claims , Food Drug , Cosmetic Act ,